Description
Premium BPC-157 Peptide for Sale | ≥99% Purity | 48-Hour Delivery Across EU & UK
BPC-157: The Revolutionary Body Protection Compound for Regenerative Research
eupeptidelap.co.uk is proud to present BPC-157 (Body Protection Compound-157), a premium research-grade pentadecapeptide manufactured to the highest analytical standards. As a trusted peptide vendor uk and leading EU peptide supplier, we provide researchers across Europe with BPC-157 for sale that delivers exceptional purity, consistency, and documented quality for advanced studies in tissue regeneration, wound healing, and angiogenesis .
BPC-157 is a 15-amino acid synthetic peptide (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) with a molecular weight of 1419 Da . It is derived from a protective protein found in human gastric juice and was first described in the scientific literature in 1993 by Sikirić and colleagues . The peptide demonstrates remarkable chemical stability, maintaining its biological activity even under harsh conditions such as enzymatic degradation, gastric fluid, and room temperature storage .
The peptide exerts its effects through multiple interconnected mechanisms that have been elucidated through decades of preclinical research. A recent breakthrough study published in Cell Communication and Signaling (2026) revealed that intracellular BPC-157 engages the E3 ubiquitin ligase adaptor protein FBXO22 through its proline residue at position 3 . This interaction results in the formation of a protein complex that suppresses the ubiquitination and subsequent proteasomal degradation of the transcription factor BACH1, leading to significant stabilization of BACH1 protein levels . The consequent accumulation of BACH1 enhances critical processes in vascular regeneration, namely, the proliferation and tube-forming capacity of vascular endothelial cells .
For researchers seeking to buy peptide online EU for investigations into tissue repair, inflammatory bowel disease, musculoskeletal recovery, or neuroregeneration, eupeptidelap.co.uk offers this premium research compound with comprehensive documentation, including Certificates of Analysis and batch-specific purity data. Whether your laboratory is based in London, Berlin, Paris, or anywhere in the European Union, our guaranteed 48 hour delivery peptide service ensures your research continues without interruption.
The Scientific Foundation of BPC-157 Research
Discovery and Historical Context
BPC-157 was originally identified as a naturally occurring peptide endogenous to human gastric juice that promotes mucosal integrity and homeostasis . Early research established its cytoprotective and pro-healing effects throughout the gastrointestinal tract, including healing GI ulcers, anastomotic sites, various GI fistulas, as well as in models of inflammatory bowel disease . Over three decades of research, the peptide’s applications have expanded far beyond gastrointestinal healing to encompass musculoskeletal repair, wound healing, angiogenesis, and neuroprotection .
Mechanism of Action: The FBXO22-BACH1 Axis
A landmark study published in 2026 has elucidated a primary molecular mechanism underlying BPC-157’s proangiogenic effects . Using biotin-labeled BPC-157 and co-immunoprecipitation assays followed by mass spectrometry, researchers identified FBXO22 as the strongest interactor with BPC-157 . Immunofluorescence and ELISA further confirmed the intracellular colocalization of BPC-157 with FBXO22 .
Molecular docking simulations predicted a stable binding conformation with electrostatic interactions dominating the binding interface. Hydrogen bonding was observed between residues G1, E2, P3, K7, and V15 of BPC-157 and E31, R58, and E183 of FBXO22 . Alanine-scanning mutagenesis confirmed that the proline residue at position 3 serves as the key binding site for FBXO22 .
This interaction suppresses the ubiquitination and proteasomal degradation of the transcription factor BACH1, leading to its stabilization . BACH1 accumulation then enhances the proliferation and tube-forming capacity of vascular endothelial cells, driving angiogenesis and tissue repair .
Additional Molecular Pathways
Beyond the FBXO22-BACH1 axis, BPC-157 activates multiple pathways involved in tissue regeneration :
-
VEGF-Dependent Pathway: BPC-157 activates VEGFR2–PI3K–Akt–eNOS signaling, promoting NO production, angiogenesis, vasodilation, and vascular stability
-
VEGF-Independent Pathway: The peptide also activates Src–caveolin-1–eNOS signaling, further supporting endothelial function
-
ERK1/2 Activation: In endothelial cells, BPC-157 activates ERK1/2 signaling, enhancing proliferation, migration, and vascular tube formation through transcription factors like c-Fos, c-Jun, and Egr-1
-
Cytoprotective Factor Upregulation: BPC-157 upregulates heme oxygenase-1 (HO-1) and heat shock proteins, preserving mitochondrial integrity and reducing oxidative stress
-
Growth Hormone Receptor Enhancement: Preclinical studies show BPC-157 enhances growth hormone receptor expression
-
Anti-Inflammatory Effects: The peptide reduces inflammatory cytokines while modulating the nitric oxide system
Key Research Applications
Gastrointestinal Research: BPC-157 was first identified in gastric juice and has been extensively studied for its gastroprotective properties . A systematic review published in The American Journal of Gastroenterology (2025) examined 36 studies from 1993 to 2025 and found that BPC-157 improved functional and structural outcomes in inflammatory bowel disease, GI ulcer, NSAID-induced injury, various GI fistula, and repaired anastomotic site models . The peptide promotes mucosal integrity and homeostasis throughout the gastrointestinal tract, making it particularly valuable for research into gut barrier function and inflammatory conditions .
Musculoskeletal Recovery Research: BPC-157 has demonstrated remarkable effects on tendon, ligament, and muscle healing. In rodent models of muscle contusion, BPC-157 treatment significantly accelerated tissue regeneration, with quantitative histomorphometry showing improved new collagen fiber formation rates and interfiber spacing recovery (0.62 ± 0.21 μm vs 0.18 ± 0.15 μm, p < 0.005) . Studies in rats with Achilles tendon injuries showed accelerated healing with reduced wound size and depth . The peptide promotes the repair of damaged cartilage, tendons, and ligaments, improving joint function .
Angiogenesis Research: Comparative angiogenic profiling through CD31 immunohistochemistry revealed a dose-dependent increase in microvascular density in BPC-157-treated rodent skeletal muscle contusion models (muscle injury model: 1.7 ± 0.4 vessels vs. 6.2 ± 3.2 in the BPC-157-treated group, p < 0.001) . This neovascularization was consistently observed in murine full-thickness burn injuries and rat dermal incisional wounds, suggesting that BPC-157 plays a fundamental role in promoting endothelial cell proliferation and vascular network reconstitution during tissue repair .
Cell Proliferation and Tube Formation: In human umbilical vein endothelial cells (HUVECs), BPC-157 treatment at concentrations of 5 µg/mL, 10 µg/mL, or 20 µg/mL significantly enhanced cell viability in a concentration-dependent manner . The peptide also promoted more extensive tube formation in a dose-dependent manner when HUVECs were plated on Matrigel . Mechanistically, BPC-157 significantly upregulated the expression of PDGF subunit B (PDGFB), FGF2, FGF receptor (FGFR), and EGF receptor (EGFR), without altering VEGF and EGF secretion .
Gut-Brain Axis Research: Emerging research published in 2026 highlights BPC-157’s modulation of the gut–brain axis (GBA), affecting neural and gastrointestinal functions . Evidence suggests it may promote neuroprotection, regulate inflammation, and influence mood and cognition, with potential relevance for neurodegenerative and psychiatric disorders . BPC-157 enhances neuronal survival, promotes angiogenesis and synaptic plasticity, and modulates key neurotransmitter systems, including dopaminergic, serotonergic, and GABAergic pathways . In animal models, BPC-157 improves motor coordination, cognitive performance, and recovery after neural injury .
Wound Healing Research: During the development of “HuBPP Body Protective Polypeptide Injection,” systematic pharmacodynamic evaluations using standardized experimental models—murine full-thickness burn injuries, rat dermal incisional wounds, and rodent skeletal muscle contusion models—demonstrated significant therapeutic efficacy of BPC-157 in accelerating tissue regeneration . Daily administration of BPC-157 (5–40 µg/kg) via subcutaneous injection for 7 consecutive days produced marked improvements in healing outcomes compared to saline controls .
Inflammatory Condition Research: BPC-157’s anti-inflammatory properties make it valuable for researching inflammatory conditions. It modulates inflammatory cytokines and promotes anti-inflammatory substances, supporting the healing process . Research suggests it reduces pro-inflammatory cytokines while supporting the body’s own antioxidant defences .
Safety Profile in Preclinical Studies: Preclinical safety studies have shown no adverse effects across several organ systems, with LD1 not achieved . Pharmacokinetic profiling revealed linear dose‒exposure relationships, with [³H]BPC-157 rapidly metabolized into small peptides and ultimately tritium-labeled proline for normal amino acid catabolism/excretion . However, no clinical safety data is available to date, and its use remains investigational .
Quality Assurance: Setting the Standard for Research Compounds
Manufacturing Excellence
eupeptidelap.co.uk sources BPC-157 from certified GMP facilities with rigorous quality control protocols:
-
HPLC Purity Analysis: ≥99% purity verified by high-performance liquid chromatography
-
Mass Spectrometry Verification: Molecular weight confirmation (1419 Da) via LC-HRMS
-
Batch-Specific Certificates of Analysis: Complete documentation for each production run
-
Sterile Manufacturing: Produced under stringent conditions in ISO-certified laboratories
-
Third-Party Lab Testing: Independent verification of purity and potency
Chemical and Product Specifications
| Specification | Detail |
|---|---|
| Product Name | BPC-157 (Body Protection Compound-157) |
| Amino Acid Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| Molecular Formula | C₆₂H₉₈N₁₆O₂₂ |
| Molecular Weight | 1419 Da |
| Purity | ≥99% (HPLC verified) |
| Appearance | White to off-white lyophilized powder |
| Form | Lyophilized powder |
| Solubility | Soluble in sterile 18MΩ-cm H₂O at ≥100 µg/ml, further dilutable to other aqueous solutions |
| Half-Life | <30 minutes |
| Metabolism | Liver; rapidly metabolized into small peptides |
| Elimination | Renal clearance |
| Storage (Lyophilized) | -20°C or below; stable at room temperature for 3 weeks; protect from light and moisture |
| Storage (Reconstituted) | 4°C for 2-7 days; for long-term, store below -18°C with carrier protein |
| Shipping | Ice packs with protective packaging |
| Intended Use | Research and laboratory use only |
| Documentation | Certificate of Analysis provided with each batch |
Stability and Handling Guidelines
Lyophilized Powder Storage: Store lyophilized BPC-157 powder at -20°C or below for long-term stability . While stable at room temperature for up to 3 weeks, refrigeration or freezing is recommended for extended storage. Keep desiccated and protected from light .
Reconstitution Protocol :
-
Allow vial and solvent to reach ambient temperature before opening to prevent condensation
-
Reconstitute using sterile 18MΩ-cm H₂O at not less than 100 µg/ml, which can then be further diluted to other aqueous solutions
-
Inject solvent slowly down the inside wall of the vial to minimize foaming
-
Gently swirl or roll the vial until fully dissolved—do not shake vigorously
-
Label the vial with the date of reconstitution
-
Refrigerate immediately at 4°C
Reconstituted Solution Storage: Store reconstituted BPC-157 at 4°C for 2-7 days . For long-term storage, aliquot into single-use portions, add a carrier protein (0.1% HSA or BSA), and store below -18°C . Prevent repeated freeze-thaw cycles .
Protection from Light and Moisture:
-
Store in original packaging protected from light
-
Keep vials tightly sealed when not in use
-
Allow refrigerated vials to reach room temperature before opening to prevent condensation
Key Benefits
-
Premium Quality Manufacturing: GMP-certified production, ≥99% HPLC-verified purity
-
Well-Characterized Mechanism: Novel FBXO22-BACH1 axis elucidated in 2026 research
-
Angiogenesis Stimulation: Increases microvascular density in injury models (1.7 vs 6.2 vessels, p < 0.001)
-
Endothelial Cell Proliferation: Enhances HUVEC viability in concentration-dependent manner
-
Tube Formation Enhancement: Promotes capillary-like structure formation on Matrigel
-
Growth Factor Upregulation: Increases PDGFB, FGF2, FGFR, and EGFR expression
-
Gastrointestinal Research: Extensive evidence in IBD, ulcer, and GI injury models
-
Musculoskeletal Recovery: Accelerates tendon, ligament, and muscle healing
-
Wound Healing: Promotes re-epithelialization and tissue regeneration in burn and incisional models
-
Gut-Brain Axis Research: Modulates neurotransmitter systems and promotes neuroprotection
-
Anti-Inflammatory Effects: Reduces inflammatory cytokines and supports antioxidant defences
-
Synaptic Plasticity: Enhances neuronal survival and cognitive performance in animal models
-
Cytoprotective Properties: Upregulates HO-1 and heat shock proteins
-
Nitric Oxide Modulation: Activates both VEGF-dependent and independent eNOS pathways
-
Favorable Safety Profile: No adverse effects in preclinical studies; LD1 not achieved
-
Well-Characterized Pharmacokinetics: Linear dose-exposure relationships, rapid metabolism
-
Comprehensive Documentation: Certificates of Analysis with batch-specific purity data
-
48-Hour EU & UK Delivery: Rapid shipping to research facilities across Europe
-
Batch Consistency: Rigorous quality control ensures lot-to-lot reproducibility
-
EU Sourced: Available from within the European Union
Frequently Asked Questions
Q: What is BPC-157 and where does it come from?
A: BPC-157 (Body Protection Compound-157) is a 15-amino acid synthetic peptide (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) with a molecular weight of 1419 Da . It is derived from a protective protein found in human gastric juice and was first described in the scientific literature in 1993 .
Q: What is the mechanism of action of BPC-157?
A: BPC-157 binds to FBXO22 through its proline residue at position 3, suppressing the ubiquitination and degradation of the transcription factor BACH1 . BACH1 stabilization enhances endothelial cell proliferation and tube formation, driving angiogenesis and tissue repair . The peptide also activates VEGF-dependent and independent pathways, ERK1/2 signaling, and upregulates cytoprotective factors .
Q: What purity level can I expect when I buy BPC-157 from eupeptidelap.co.uk?
A: All BPC-157 from eupeptidelap.co.uk is tested to ≥99% purity by HPLC. Each batch is individually analyzed, and Certificates of Analysis are provided with every order, ensuring you receive material suitable for rigorous research applications.
Q: What is the half-life of BPC-157?
A: BPC-157 has a half-life of less than 30 minutes . It is metabolized in the liver and cleared by the kidneys, with [³H]BPC-157 rapidly metabolized into small peptides and ultimately tritium-labeled proline for normal amino acid catabolism/excretion .
Q: How should I store BPC-157 for long-term stability?
A: Store lyophilized BPC-157 powder at -20°C or below, protected from light and moisture . While stable at room temperature for up to 3 weeks, refrigeration or freezing is recommended for extended storage. Keep desiccated .
Q: What is the recommended reconstitution protocol for BPC-157?
A: Reconstitute using sterile 18MΩ-cm H₂O at not less than 100 µg/ml, which can then be further diluted to other aqueous solutions . Inject solvent slowly, gently swirl—do not shake. After reconstitution, store at 4°C for 2-7 days . For long-term storage, add a carrier protein (0.1% HSA or BSA) and store below -18°C .
Q: What research areas commonly use BPC-157?
A: BPC-157 is widely used in gastrointestinal research (IBD, ulcers, NSAID injury) , musculoskeletal recovery studies (tendon, ligament, muscle healing) , wound healing research , angiogenesis research , neuroprotection and gut-brain axis research , and inflammatory condition research .
Q: Is BPC-157 legal to purchase in the UK?
A: BPC-157 is not approved for human use by the MHRA in the UK or the FDA in the US . It is typically sold for research purposes only, meaning you can legally purchase it to study its effects or for non-human testing, but you cannot market or sell it for human consumption . At eupeptidelap.co.uk, all products are intended for research and laboratory use only.
Q: Do you ship BPC-157 to EU countries?
A: Yes. As a dedicated EU peptide supplier, we ship BPC-157 to all European Union member states with our guaranteed 48 hour delivery peptide service. Our EU fulfilment centre ensures rapid delivery without customs delays. All shipments use ice packs with protective packaging to maintain compound integrity during transit.
Q: What documentation do you provide with BPC-157 orders?
A: Every order includes a Certificate of Analysis (COA) with batch-specific purity data. Additional documentation, including HPLC chromatograms and mass spectrometry data, is available upon request for researchers requiring comprehensive analytical verification.
Q: Does BPC-157 have applications in nervous system research?
A: Yes. Emerging research demonstrates BPC-157 modulates the gut–brain axis, enhancing neuronal survival, promoting synaptic plasticity, and modulating dopaminergic, serotonergic, and GABAergic pathways . In animal models, BPC-157 improves motor coordination, cognitive performance, and recovery after neural injury .
Q: What is the role of BPC-157 in angiogenesis research?
A: BPC-157 promotes angiogenesis through multiple mechanisms: FBXO22-BACH1-mediated endothelial proliferation , VEGF-dependent (VEGFR2–PI3K–Akt–eNOS) and independent (Src–caveolin-1–eNOS) pathways , and ERK1/2 activation . In animal models, BPC-157 increased microvascular density from 1.7 to 6.2 vessels (p < 0.001) .
Q: Do you offer bulk quantities of BPC-157 for institutional research?
A: Yes. We accommodate bulk orders for research institutions. Contact our team at sales@eupeptidelap.co.uk for volume pricing, custom requirements, and supply agreements for ongoing research programs.
Q: Is BPC-157 banned in sports?
A: Yes. BPC-157 is currently prohibited by the World Anti-Doping Agency and does not carry FDA approval . It was listed as a prohibited substance by all NCAA and professional anti-doping sporting agencies in 2022 . Researchers working with athletic populations should be aware of these regulations. ...........................................
Advance Your Research with BPC-157
eupeptidelap.co.uk is your trusted source for BPC-157, the premium choice for researchers investigating tissue regeneration, angiogenesis, gastrointestinal health, and neuroprotection. With over three decades of preclinical research supporting its cytoprotective and regenerative properties and a newly elucidated molecular mechanism involving the FBXO22-BACH1 axis , BPC-157 represents one of the most extensively studied and versatile peptides in the research community.
Whether you are exploring angiogenesis pathways, designing wound healing studies, investigating inflammatory bowel disease, or researching gut-brain axis modulation, our rigorously tested compound provides the quality and consistency your work demands. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Order today and experience the eupeptidelap.co.uk difference – premium quality, rapid 48-hour delivery across the EU and UK, and expert support for the European research community.
